Insmed Inc
General ticker "INSM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $12.7B
Insmed Inc follows the US Stock Market performance with the rate: 53.5%.
Estimated limits based on current volatility of 2.1%: low 68.79$, high 71.69$
Factors to consider:
- US accounted for 73.5% of revenue in the fiscal year ended 2023-12-31
- Current price 69.2% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [20.26$, 41.71$]
- 2024-12-30 to 2025-12-30 estimated range: [19.73$, 40.22$]
Financial Metrics affecting the INSM estimates:
- Negative: Non-GAAP EPS, $ of -5.33 <= 0.10
- Negative: Operating profit margin, % of -69.93 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -12.17 <= 2.35
- Positive: -3.48 < Investing cash flow per share, $ of -1.59
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term INSM quotes
Long-term INSM plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $188.46MM | $245.36MM | $305.21MM |
| Operating Expenses | $563.55MM | $702.68MM | $1,014.83MM |
| Operating Income | $-375.09MM | $-457.32MM | $-709.63MM |
| Non-Operating Income | $-61.32MM | $-22.83MM | $-37.39MM |
| Interest Expense | $40.47MM | $26.45MM | $81.69MM |
| R&D Expense | $272.74MM | $397.52MM | $571.01MM |
| Income(Loss) | $-436.41MM | $-480.15MM | $-747.01MM |
| Taxes | $-1.76MM | $1.38MM | $2.56MM |
| Profit(Loss) | $-434.65MM | $-481.53MM | $-749.57MM |
| Stockholders Equity | $410.47MM | $87.95MM | $-331.92MM |
| Inventory | $67.01MM | $69.92MM | $83.25MM |
| Assets | $1,243.51MM | $1,656.43MM | $1,329.84MM |
| Operating Cash Flow | $-363.30MM | $-400.44MM | $-536.25MM |
| Capital expenditure | $7.29MM | $9.88MM | $13.29MM |
| Investing Cash Flow | $-64.28MM | $-34.58MM | $-223.60MM |
| Financing Cash Flow | $612.55MM | $793.27MM | $168.44MM |
| Earnings Per Share* | $-3.88 | $-3.91 | $-5.34 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.